DOI: https://dx.doi.org/10.18203/issn.2455-4510.IntJResOrthop20222998
Published: 2022-11-29

Clinical outcome of early-stage knee osteoarthritis after intra-articular platelet rich plasma injection

Chaitanya D. Khanolkar, Prafulla G. Herode, Vinoth Kumar L., Franklin Francis Chazhoor

Abstract


Background: Osteoarthritis (OA) is a degenerative joint disease due to degradation of articular cartilage, proliferative reformation of subchondral bone and low degree of synovitis resulting in reduced quality of life (QOL), being the major cause of pain and disability in the elderly population. Platelet-rich plasma (PRP) is an autologous mixture of concentrated platelets and growth factors produced by centrifugation of whole blood, used to treat bone, tendon and ligament injuries. The growth factors released by PRP have been shown to promote cell recruitment, proliferation and angiogenesis resulting in a decrease in the expression of inflammatory enzymes. The aim was to study the effectiveness of intra-articular PRP injections in early-stage OA knee patients and to evaluate the clinical outcome and QOL at 6 months.

Methods: We conducted an observational study of 100 patients with early OA knee changes with age group >50 years and injected their knees with PRP injections and serial follow up assessment was done.

Results: We saw significant improvement in quality of lives evaluated as per world health organization quality of life (WHOQOL) questionnaire after PRP injections on their follow-up. Significant reduction in pain, reduction in joint stiffness and improvement in physical activities shown by significant reduction in Western Ontario and McMaster universities osteoarthritis index (WOMAC) scores.

Conclusions: OA of knee is one of the commonest rheumatological problems after 50 years of age. It was commonly observed in females more than 60 years age with sedentary lifestyle. PRP therapy has given excellent results in pain relief, reduction of joint stiffness and improvement in physical activities and improvement in QOL.


Keywords


OA, PRP, Knee joint, QOL

Full Text:

PDF

References


Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin N Am. 2013;39:1-19.

Adatia A, Rainsford KD, Kean WF. Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy. J Pharm Pharmacol. 2012;64:617-25.

Akinpelu AO, Alonge TO, Adekanla BA, Odole AC. Prevalence and pattern of symptomatic knee osteoarthritis in Nigeria: A community-based study. Internet J Allied Health Sci Pract. 2009;7:3.

Davis MA, Ettinger WH, Neuhaus JM, Hauck WW. Sex differences in osteoarthritis of the knee. The role of obesity. Am J Epidemiol. 1988;127:1019-30.

Campbell KA, Saltzman BM, Mascarenhas R. Does intraarticular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthrosc J Arthrosc Relat Surg. 2015;31:2213-21.

Sundman EA, Cole BJ, Karas V, Della Valle C, Tetreault MW, Mohammed HO et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med. 2014;42:35-41.

Ogino Y, Ayukawa Y, Kukita T, Koyano K. The contribution of platelet-derived growth factor, transforming growth factor-β1, and insulinlike growth factor-I in platelet-rich plasma to the proliferation of osteoblastlike cells. Oral Surgery, Oral Med Oral PatholOral Radiol Endodontol. 2006;101:724-9.

Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents. 2012;26:3-22.

Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet rich plasma: a short overview of certain bioactive components. Open Med. 2012;11:242-7.

Fernandes G, Yang S. Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering. Bone Res. 2016;4:16036.

Mifune Y, Matsumoto T, Takayama K, Ota S, Li H, Meszaros LB et al. The effect of plateletrich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthr Cartil. 2013;21:175-85.

Mohammed F, Aggarwal V, Kushwaha SS, Verma A, Khan YA. Role of platelet rich plasma in patients of osteoarthritis knee – a prospective study. Indian J Orthop Surg. 2017;3(2):171-5.

Ramesh R, Madhan J, Kartavya C, Sabarisk K, Likhith D et al. A Randomized Controlled Trial on Functional Outcome and Effectiveness of Autologous Platelet Rich Plasma Therapy Vs Corticosteroid Injection in Early Knee Osteoarthritis. Nov Tech Arthritis Bone Res. 2019;3(4):555617.

Dhaniwala NS, Patil B, Dhaniwala M. Role of Platelet Rich Plasma (PRP) in Osteoarthritis Knee. IP J Indian Orthop Rheumatol Assoc. 2017;3(2):73-5.

Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131:311-7.

Raeissadat SA, Rayegani SM, Babaee M, Ghorbani E. The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis. Pain Res Treatment. 2013;165967.

Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987;30(8):914-8.

McAlindon TE, Bannuru RR, Sullivan MC. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-88.

Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351-61.